Earth IQs are crashing, but Mars is rising. Escape the Dumbpocalypse with this survival guide on longevity science, neurotech, and cognitive resilience.
In a May 7, 2024 press release, Seragon Biosciences announced that its aging intervention drug candidate, SRN-901, achieved one of the largest extensions of
Discover cutting-edge aging therapies like epigenetic reprogramming, senolytics, and CRISPR to reverse cellular decline and extend healthspan. The future of longevity starts now.